KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Inventory Average (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Inventory Average for 12 consecutive years, with $80.4 million as the latest value for Q4 2023.

  • On a quarterly basis, Inventory Average fell 7.91% to $80.4 million in Q4 2023 year-over-year; TTM through Dec 2023 was $80.4 million, a 7.91% decrease, with the full-year FY2024 number at $65.9 million, down 22.05% from a year prior.
  • Inventory Average was $80.4 million for Q4 2023 at Supernus Pharmaceuticals, down from $87.0 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $87.4 million in Q1 2022 to a low of $25.5 million in Q1 2020.
  • A 5-year average of $49.3 million and a median of $42.1 million in 2020 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: skyrocketed 93.06% in 2021, then dropped 7.91% in 2023.
  • Supernus Pharmaceuticals' Inventory Average stood at $26.1 million in 2019, then skyrocketed by 74.15% to $45.4 million in 2020, then increased by 19.64% to $54.3 million in 2021, then surged by 60.85% to $87.4 million in 2022, then decreased by 7.91% to $80.4 million in 2023.
  • Per Business Quant, the three most recent readings for SUPN's Inventory Average are $80.4 million (Q4 2023), $87.0 million (Q3 2023), and $87.4 million (Q4 2022).